19-41879574-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001783.4(CD79A):c.419C>A(p.Thr140Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,611,714 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 4 hom. )
Consequence
CD79A
NM_001783.4 missense
NM_001783.4 missense
Scores
2
5
5
Clinical Significance
Conservation
PhyloP100: 1.52
Genes affected
CD79A (HGNC:1698): (CD79a molecule) The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-alpha protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.011353046).
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79A | NM_001783.4 | c.419C>A | p.Thr140Asn | missense_variant | 3/5 | ENST00000221972.8 | NP_001774.1 | |
CD79A | NM_021601.4 | c.305C>A | p.Thr102Asn | missense_variant | 3/5 | NP_067612.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79A | ENST00000221972.8 | c.419C>A | p.Thr140Asn | missense_variant | 3/5 | 1 | NM_001783.4 | ENSP00000221972.3 | ||
CD79A | ENST00000444740.2 | c.305C>A | p.Thr102Asn | missense_variant | 3/5 | 1 | ENSP00000400605.1 | |||
CD79A | ENST00000597454.2 | c.664C>A | p.Pro222Thr | missense_variant | 2/4 | 3 | ENSP00000468922.2 |
Frequencies
GnomAD3 genomes AF: 0.00133 AC: 202AN: 152052Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
202
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00134 AC: 328AN: 243868Hom.: 0 AF XY: 0.00134 AC XY: 178AN XY: 132526
GnomAD3 exomes
AF:
AC:
328
AN:
243868
Hom.:
AF XY:
AC XY:
178
AN XY:
132526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00184 AC: 2685AN: 1459544Hom.: 4 Cov.: 32 AF XY: 0.00178 AC XY: 1289AN XY: 725940
GnomAD4 exome
AF:
AC:
2685
AN:
1459544
Hom.:
Cov.:
32
AF XY:
AC XY:
1289
AN XY:
725940
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00133 AC: 202AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00117 AC XY: 87AN XY: 74396
GnomAD4 genome
AF:
AC:
202
AN:
152170
Hom.:
Cov.:
32
AF XY:
AC XY:
87
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
21
ExAC
AF:
AC:
132
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 05, 2022 | Reported in two patients with common variable immunodeficiency disorder who also harbored an additional missense variant in the CD79A gene; however, the phase was not reported for these variants (van Schouwenburg et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24728327, 26122175, 33772212) - |
Agammaglobulinemia 3, autosomal recessive Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 20, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 15, 2023 | The CD79A c.419C>A; p.Thr140Asn variant (rs148797987; ClinVar Variation ID: 133835) is reported in the literature in an individual affected with common variable immunodeficiency, although it was not demonstrated to be pathogenic (Van Schouwenburg 2015). This variant is found in the non-Finnish European population with an overall allele frequency of 0.13% (363/275,170 alleles) in the Genome Aggregation Database. The threonine at codon 140 is highly conserved but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.408). Based on the available information, the clinical significance of this variant is uncertain. References: Van Schouwenburg et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol. 2015 Oct;160(2):301-14. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
Sift4G
Pathogenic
D
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at